Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-04 4:31 pm Purchase | 2025-07-28 | 13G | ImageneBio Inc IMA | Deep Track Capital, LP | 878,516 7.860% | 878,516 (New Position) | Filing History |
| 2025-08-04 4:29 pm Sale | 2025-07-28 | 13G | Ikena Oncology, Inc. IKNA | Deep Track Capital, LP | 0 0.000% | -209,626 (Position Closed) | Filing History |
| 2025-07-30 9:28 pm Purchase | 2025-07-25 | 13D | Ikena Oncology, Inc. IKNA | ORBIMED ADVISORS LLC | 773,754 6.920% | 106,345 (+15.93%) | Filing History |
| 2025-07-29 4:53 pm Purchase | 2025-07-25 | 13D | ImageneBio Inc IMA | Atlas Venture Fund X, L.P. | 241,800 2.100% | 241,800 (New Position) | Filing History |
| 2025-07-28 2:16 pm Purchase | 2025-07-25 | 13D | ImageneBio Inc IMA | BML Investment Partners, L.P. | 220,832 1.900% | 220,832 (New Position) | Filing History |
| 2025-06-18 8:23 pm Purchase | 2025-06-14 | 13D | Ikena Oncology, Inc. IKNA | ORBIMED ADVISORS LLC | 667,409 16.710% | 484,984 (+265.85%) | Filing History |
| 2025-06-16 12:21 pm Purchase | 2025-06-16 | 13D | Ikena Oncology, Inc. IKNA | BML Investment Partners, L.P. | 340,842 8.500% | 37,020 (+12.18%) | Filing History |
| 2025-02-14 4:32 pm Purchase | 2025-02-07 | 13G | Ikena Oncology, Inc. IKNA | Deep Track Capital, LP | 209,626 5.210% | 209,626 (New Position) | Filing History |
| 2025-02-14 4:22 pm Sale | 2024-12-31 | 13G | Ikena Oncology, Inc. IKNA | BIOTECHNOLOGY VALUE FUND L P | 333,880 8.300% | -63,550 (-15.99%) | Filing History |
| 2025-02-14 10:47 am Unchanged | 2024-12-31 | 13G | Ikena Oncology, Inc. IKNA | BML Investment Partners, L.P. | 303,822 7.600% | 0 (Unchanged) | Filing History |
| 2025-02-13 4:22 pm Sale | 2024-12-31 | 13G | Ikena Oncology, Inc. IKNA | GILEAD SCIENCES INC. GILD | 126,776 3.600% | -117,513 (-48.10%) | Filing History |
| 2024-12-31 3:44 pm Purchase | 2024-12-23 | 13G | Ikena Oncology, Inc. IKNA | BML Investment Partners, L.P. | 303,822 7.600% | 303,822 (New Position) | Filing History |
| 2024-11-14 5:05 pm Purchase | 2024-09-30 | 13G | Context Therapeutics Inc. CNTX | Blue Owl Capital Holdings LP | 4,091,118 8.480% | 4,091,118 (New Position) | Filing History |
| 2024-11-13 4:05 pm Unchanged | 2024-09-30 | 13G | Ikena Oncology, Inc. IKNA | BRISTOL MYERS SQUIBB CO BMY | 177,762 4.400% | 0 (Unchanged) | Filing History |
| 2024-03-11 08:19 am Sale | 2024-03-08 | 13G | Ikena Oncology, Inc. IKNA | FMR LLC | 101,250 2.771% | -247,441 (-70.96%) | Filing History |
| 2024-02-14 4:57 pm Sale | 2023-12-31 | 13G | Ikena Oncology, Inc. IKNA | Citadel Advisors LLC | 14,848 0.400% | -164,746 (-91.73%) | Filing History |
| 2024-02-14 4:48 pm Unchanged | 2023-12-31 | 13G | Ikena Oncology, Inc. IKNA | Omega Fund VI, L.P. | 187,427 4.700% | 0 (Unchanged) | Filing History |
| 2024-02-14 09:47 am Purchase | 2023-12-31 | 13G | Ikena Oncology, Inc. IKNA | BIOTECHNOLOGY VALUE FUND L P | 397,430 9.900% | 188,841 (+90.53%) | Filing History |
| 2024-02-09 09:16 am Purchase | 2024-02-08 | 13G | Ikena Oncology, Inc. IKNA | FMR LLC | 348,691 9.545% | 38,310 (+12.34%) | Filing History |
| 2023-10-19 3:33 pm Purchase | 2023-10-11 | 13G | Ikena Oncology, Inc. IKNA | GILEAD SCIENCES INC. GILD | 244,289 6.700% | 244,289 (New Position) | Filing History |